Mathey, Guillaume http://orcid.org/0000-0002-5747-9169
Pisché, Guillaume
Soudant, Marc
Pittion-Vouyovitch, Sophie
Guillemin, Francis
Debouverie, Marc
Epstein, Jonathan
Article History
Received: 20 October 2020
Revised: 26 February 2021
Accepted: 26 February 2021
First Online: 31 March 2021
Compliance with ethical standards
:
: Guillaume Mathey has served on boards by BIOGEN, ROCHE, and NOVARTIS in the past 3 years but never received any personal or institutional financial compensation. Guillaume Pisché reports no competing interests. Marc Soudant reports no competing interests. Sophie Pittion-Vouyovitch has served on boards and received personal financial compensation by BIOGEN, ROCHE, TEVA, and NOVARTIS in the past 3 years. Francis Guillemin reports no competing interests. Marc Debouverie reports no competing interests. Jonathan Epstein reports no competing interests.
: Data collection was approved by the French National Commission for Data Protection and Liberties (CNIL n°913001). All the patients of the ReLSEP database are informed that their data are recorded and may be used for research purposes according to the French legislation. Patient written consent was obtained according to the Declaration of Helsinki.